Prescription drug · BLA
Insulin Aspart NDC 73070-100
Insulin aspart 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous · Novo Nordisk Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73070-100-11 | 7307001001173070010011 | 1 VIAL, GLASS in 1 CARTON (73070-100-11) / 10 mL in 1 VIAL, GLASSMarketed from Sep 10, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Insulin Aspart
- Generic name (nonproprietary)
- insulin aspart
- Active ingredients
- Insulin aspart — 100 [iU]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- Novo Nordisk Pharma, Inc.NDC labeler code 73070
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 020986
- Marketing start
- Marketing end
- Other FDA classes
- Insulin (Chemical structure)
- Identifiers
- Product ID 73070-100_18e1bdfe-0180-4988-9797-5ee4660e3840SPL ID 18e1bdfe-0180-4988-9797-5ee4660e3840SPL set ID bee5b358-c863-420b-be73-ced2e920c499RxCUI 311040, 1653196, 1653202UNII D933668QVX
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N473070010011followed by a unit qualifier and the quantityPackage 73070-0100-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Insulin Aspart is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Insulin Aspart is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).
Excerpt only. Read the full label for complete information.
About NDC 73070-100
- What is NDC 73070-100?
- 73070-100 is the product NDC for Insulin Aspart, Insulin aspart 100 [iU]/mL injection, solution, listed with the FDA by Novo Nordisk Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Insulin Aspart.
- What is the active ingredient?
- Insulin aspart.
- Who is the labeler?
- Novo Nordisk Pharma, Inc., NDC labeler code 73070. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Insulin Aspart?
- 5 other product NDCs are listed under this name. See all Insulin Aspart NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Insulin Aspart products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | REMEDYREPACK INC. | 70518-3865 | 70518-3865-00 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4956 | 50090-4956-00 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-103 | 73070-0103-15 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4955 | 50090-4955-00 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-102 | 73070-0102-15 |
Other NDCs under BLA 020986
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4955 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4956 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | REMEDYREPACK INC. | 70518-3865 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-102 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-103 |
| Insulin Diluting Medium for NovoLogwater injection | Water 1 mL/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2001 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2100 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2101 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-3303 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-6338 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-6339 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-7501 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1664 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1678 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4500 |